| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 4.98 | 19.31 | 10.35 | 25.4 | 169.38 |
| Other Income | 3.2 | 1.3 | 3.94 | 1.16 | 6.35 |
| Stock Adjustments | -3.33 | 5.63 | -1.54 | 0.91 | -16.34 |
| Total Income | 4.85 | 26.24 | 12.75 | 27.47 | 159.39 |
| EXPENDITURE : | |||||
| Raw Materials | 11.72 | 13.62 | 0.94 | 5.75 | 60.09 |
| Excise Duty | 0 | 0 | 0 | 0 | 0 |
| Power and Fuel Cost | 0.23 | 0.27 | 0.29 | 0.56 | 0.59 |
| Other Manufacturing Expenses | 0.54 | 0.92 | 2.1 | 7.05 | 8.21 |
| Employee Cost | 2.11 | 4.21 | 5.95 | 9.92 | 12.94 |
| Selling and Administration Expenses | 3.28 | 5.39 | 6.67 | 16.82 | 49.37 |
| Miscellaneous Expenses | 0.16 | 0.5 | 6.08 | 0.59 | 5.65 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 | 0 |
| Profit before Interest, Depreciation and Tax | -13.19 | 1.33 | -9.27 | -13.22 | 22.54 |
| Interest and Financial Charges | 1.14 | 5.36 | 6.51 | 4.99 | 4.09 |
| Profit before Depreciation and Tax | -14.33 | -4.03 | -15.78 | -18.21 | 18.45 |
| Depreciation | 6.97 | 7.19 | 7.44 | 21.72 | 13.4 |
| Profit Before Tax | -21.31 | -11.22 | -23.22 | -39.92 | 5.05 |
| Tax | 0.59 | 0 | -0.17 | -2.09 | 1.97 |
| Profit After Tax | -21.9 | -11.22 | -23.05 | -37.83 | 3.08 |
| Adjustment below Net Profit | 0 | 0 | 0 | -100.68 | -0.9 |
| P and L Balance brought forward | -91.96 | -80.74 | -57.81 | 84.97 | 79.84 |
| Appropriations | 0 | 0 | 0 | 0 | -2.95 |
| P and L Bal. carried down | -113.86 | -91.96 | -80.87 | -53.54 | 84.97 |
| Equity Dividend | 0 | 0 | 0 | 0 | -2.95 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 0 | 0 | 0 | 0 | 1.03 |
| Book Value | 14.92 | 22.22 | 25.68 | 34.75 | 88 |
| Extraordinary Items | 0 | 0.02 | 0.21 | -0.01 | 0.01 |
| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Share Capital | 30 | 30 | 30 | 30 | 30 |
| Reserves and Surplus | 14.75 | 36.66 | 47.03 | 74.24 | 233.98 |
| Total Shareholders Funds | 44.75 | 66.66 | 77.03 | 104.24 | 263.98 |
| Secured Loans | 22.61 | 24.62 | 31.44 | 27.54 | 31.99 |
| Unsecured Loans | 29.23 | 26.05 | 16.78 | 22.44 | 8.07 |
| Total Debt | 51.84 | 50.67 | 48.22 | 49.98 | 40.06 |
| Total Liabilities | 96.59 | 117.33 | 125.25 | 154.22 | 304.04 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 148.31 | 148.3 | 147.89 | 151.41 | 166.51 |
| Less: Accum. Depreciation | 66.97 | 60 | 52.81 | 45.79 | 27.96 |
| Net Block | 81.34 | 88.3 | 95.08 | 105.62 | 138.55 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 |
| Investments | 3.4 | 3.4 | 3.4 | 5.98 | 0.01 |
| Current Assets, Loans and Advances | |||||
| Inventories | 25.88 | 40.44 | 12 | 9.24 | 25.34 |
| Sundry Debtors | 6.57 | 5.11 | 3.72 | 16.6 | 145.49 |
| Cash and Bank Balance | 0.06 | 0.09 | 0.23 | 0.3 | 1.03 |
| Loans and Advances | 4.86 | 4.29 | 32.76 | 34.23 | 14.09 |
| Less: Current Liab. and Prov. | |||||
| Current Liabilities | 19.63 | 19.07 | 16.08 | 14.8 | 17.61 |
| Provisions | 5.89 | 5.23 | 5.86 | 2.95 | 2.84 |
| Net Current Assets | 11.85 | 25.63 | 26.77 | 42.62 | 165.5 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 96.59 | 117.33 | 125.25 | 154.22 | 304.06 |
| Contingent Liabilities | 0 | 0 | 16.53 | 16.02 | 22 |
If I had made LUMPSUM investment of ₹ 1,00,000
in Camson Bio Technologies Ltd
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
